New

Cholera Vaccines Market

2021

Cholera Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Dukoral, Shanchol, Vaxchora, Euvichol and Others); End User (Hospitals and Clinics, Research and Academic Laboratories, Others) and Geography

| Report Code: TIPRE00004078 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Cholera Vaccines Market 2028 By Product, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Cholera is a kind of infectious disease caused by the Vibrio cholerae bacteria. It's linked to severe diarrhoea, and it needs to be treated right away because if the disease isn't treated, then it can be fatal and life-threatening. Cholera is anticipated to be a global threat to public health, particularly in underdeveloped areas. Thus, cholera vaccine is essential to control cholera and its infection. There are mainly two type of cholera vaccine available in the market one in inactive vaccine and another in a live vaccine.

MARKET SCOPE



The "Global Cholera Vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cholera vaccines market with detailed market segmentation by product and end user. The report provides key statistics on the market status of the leading cholera vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product the market is segmented as, Dukoral, Shanchol, Vaxchora, Euvichol and Others.
  • Based on end user the market is segmented as, Hospitals and Clinics, Research and Academic Laboratories and Others.

MARKET DYNAMICS


Drivers:



  • Increasing prevalence of cholera and other chronic diseases.
  • Lack of proper sanitation, unhealthy eating, consumption of contaminated water and food.
  • Growing awareness about cholera management and vaccination against the disease.
  • R&D activities to develop novel approches in cholera vaccines.
  • Rising government emphasis of immunization programs.

Restraints:



  • However, high time associated with development of vaccines, and presence of stringent regulatory approvals are likelt to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cholera vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cholera vaccines market in these regions.

IMPACT OF COVID-19 ON CHOLERA VACCINES MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the cholera vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cholera vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for cholera vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cholera vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Valneva SE
  • Sanofi
  • Astellas Pharma, Inc
  • Intervet Inc
  • GlaxoSmithKline plc
  • Pfizer, Inc
  • Takeda Pharmaceutical Co., Ltd
  • Emergent BioSolutions Inc.
  • Eubiologics Co., Ltd
  • Johnson and Johnson
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Cholera Vaccines Market - By Product
    1.3.2 Cholera Vaccines Market - By End User
    1.3.3 Cholera Vaccines Market - By Region
    1.3.3.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. CHOLERA VACCINES MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. CHOLERA VACCINES MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. CHOLERA VACCINES MARKET - GLOBAL MARKET ANALYSIS
    6.1. CHOLERA VACCINES - GLOBAL MARKET OVERVIEW
    6.2. CHOLERA VACCINES - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. CHOLERA VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
    7.1. OVERVIEW
    7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
    7.3. DUKORAL
    7.3.1. Overview
    7.3.2. Dukoral Market Forecast and Analysis
    7.4. SHANCHOL
    7.4.1. Overview
    7.4.2. Shanchol Market Forecast and Analysis
    7.5. VAXCHORA
    7.5.1. Overview
    7.5.2. Vaxchora Market Forecast and Analysis
    7.6. EUVICHOL AND OTHERS
    7.6.1. Overview
    7.6.2. Euvichol and Others Market Forecast and Analysis
    8. CHOLERA VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
    8.1. OVERVIEW
    8.2. END USER MARKET FORECASTS AND ANALYSIS
    8.3. HOSPITALS AND CLINICS
    8.3.1. Overview
    8.3.2. Hospitals and Clinics Market Forecast and Analysis
    8.4. RESEARCH AND ACADEMIC LABORATORIES
    8.4.1. Overview
    8.4.2. Research and Academic Laboratories Market Forecast and Analysis
    8.5. OTHERS
    8.5.1. Overview
    8.5.2. Others Market Forecast and Analysis

    9. CHOLERA VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    9.1. NORTH AMERICA
    9.1.1 North America Cholera Vaccines Market Overview
    9.1.2 North America Cholera Vaccines Market Forecasts and Analysis
    9.1.3 North America Cholera Vaccines Market Forecasts and Analysis - By Product
    9.1.4 North America Cholera Vaccines Market Forecasts and Analysis - By End User
    9.1.5 North America Cholera Vaccines Market Forecasts and Analysis - By Countries
    9.1.5.1 United States Cholera Vaccines Market
    9.1.5.1.1 United States Cholera Vaccines Market by Product
    9.1.5.1.2 United States Cholera Vaccines Market by End User
    9.1.5.2 Canada Cholera Vaccines Market
    9.1.5.2.1 Canada Cholera Vaccines Market by Product
    9.1.5.2.2 Canada Cholera Vaccines Market by End User
    9.1.5.3 Mexico Cholera Vaccines Market
    9.1.5.3.1 Mexico Cholera Vaccines Market by Product
    9.1.5.3.2 Mexico Cholera Vaccines Market by End User
    9.2. EUROPE
    9.2.1 Europe Cholera Vaccines Market Overview
    9.2.2 Europe Cholera Vaccines Market Forecasts and Analysis
    9.2.3 Europe Cholera Vaccines Market Forecasts and Analysis - By Product
    9.2.4 Europe Cholera Vaccines Market Forecasts and Analysis - By End User
    9.2.5 Europe Cholera Vaccines Market Forecasts and Analysis - By Countries
    9.2.5.1 Germany Cholera Vaccines Market
    9.2.5.1.1 Germany Cholera Vaccines Market by Product
    9.2.5.1.2 Germany Cholera Vaccines Market by End User
    9.2.5.2 France Cholera Vaccines Market
    9.2.5.2.1 France Cholera Vaccines Market by Product
    9.2.5.2.2 France Cholera Vaccines Market by End User
    9.2.5.3 Italy Cholera Vaccines Market
    9.2.5.3.1 Italy Cholera Vaccines Market by Product
    9.2.5.3.2 Italy Cholera Vaccines Market by End User
    9.2.5.4 Spain Cholera Vaccines Market
    9.2.5.4.1 Spain Cholera Vaccines Market by Product
    9.2.5.4.2 Spain Cholera Vaccines Market by End User
    9.2.5.5 United Kingdom Cholera Vaccines Market
    9.2.5.5.1 United Kingdom Cholera Vaccines Market by Product
    9.2.5.5.2 United Kingdom Cholera Vaccines Market by End User
    9.2.5.6 Rest of Europe Cholera Vaccines Market
    9.2.5.6.1 Rest of Europe Cholera Vaccines Market by Product
    9.2.5.6.2 Rest of Europe Cholera Vaccines Market by End User
    9.3. ASIA-PACIFIC
    9.3.1 Asia-Pacific Cholera Vaccines Market Overview
    9.3.2 Asia-Pacific Cholera Vaccines Market Forecasts and Analysis
    9.3.3 Asia-Pacific Cholera Vaccines Market Forecasts and Analysis - By Product
    9.3.4 Asia-Pacific Cholera Vaccines Market Forecasts and Analysis - By End User
    9.3.5 Asia-Pacific Cholera Vaccines Market Forecasts and Analysis - By Countries
    9.3.5.1 Australia Cholera Vaccines Market
    9.3.5.1.1 Australia Cholera Vaccines Market by Product
    9.3.5.1.2 Australia Cholera Vaccines Market by End User
    9.3.5.2 China Cholera Vaccines Market
    9.3.5.2.1 China Cholera Vaccines Market by Product
    9.3.5.2.2 China Cholera Vaccines Market by End User
    9.3.5.3 India Cholera Vaccines Market
    9.3.5.3.1 India Cholera Vaccines Market by Product
    9.3.5.3.2 India Cholera Vaccines Market by End User
    9.3.5.4 Japan Cholera Vaccines Market
    9.3.5.4.1 Japan Cholera Vaccines Market by Product
    9.3.5.4.2 Japan Cholera Vaccines Market by End User
    9.3.5.5 South Korea Cholera Vaccines Market
    9.3.5.5.1 South Korea Cholera Vaccines Market by Product
    9.3.5.5.2 South Korea Cholera Vaccines Market by End User
    9.3.5.6 Rest of Asia-Pacific Cholera Vaccines Market
    9.3.5.6.1 Rest of Asia-Pacific Cholera Vaccines Market by Product
    9.3.5.6.2 Rest of Asia-Pacific Cholera Vaccines Market by End User
    9.4. MIDDLE EAST AND AFRICA
    9.4.1 Middle East and Africa Cholera Vaccines Market Overview
    9.4.2 Middle East and Africa Cholera Vaccines Market Forecasts and Analysis
    9.4.3 Middle East and Africa Cholera Vaccines Market Forecasts and Analysis - By Product
    9.4.4 Middle East and Africa Cholera Vaccines Market Forecasts and Analysis - By End User
    9.4.5 Middle East and Africa Cholera Vaccines Market Forecasts and Analysis - By Countries
    9.4.5.1 South Africa Cholera Vaccines Market
    9.4.5.1.1 South Africa Cholera Vaccines Market by Product
    9.4.5.1.2 South Africa Cholera Vaccines Market by End User
    9.4.5.2 Saudi Arabia Cholera Vaccines Market
    9.4.5.2.1 Saudi Arabia Cholera Vaccines Market by Product
    9.4.5.2.2 Saudi Arabia Cholera Vaccines Market by End User
    9.4.5.3 U.A.E Cholera Vaccines Market
    9.4.5.3.1 U.A.E Cholera Vaccines Market by Product
    9.4.5.3.2 U.A.E Cholera Vaccines Market by End User
    9.4.5.4 Rest of Middle East and Africa Cholera Vaccines Market
    9.4.5.4.1 Rest of Middle East and Africa Cholera Vaccines Market by Product
    9.4.5.4.2 Rest of Middle East and Africa Cholera Vaccines Market by End User
    9.5. SOUTH AND CENTRAL AMERICA
    9.5.1 South and Central America Cholera Vaccines Market Overview
    9.5.2 South and Central America Cholera Vaccines Market Forecasts and Analysis
    9.5.3 South and Central America Cholera Vaccines Market Forecasts and Analysis - By Product
    9.5.4 South and Central America Cholera Vaccines Market Forecasts and Analysis - By End User
    9.5.5 South and Central America Cholera Vaccines Market Forecasts and Analysis - By Countries
    9.5.5.1 Brazil Cholera Vaccines Market
    9.5.5.1.1 Brazil Cholera Vaccines Market by Product
    9.5.5.1.2 Brazil Cholera Vaccines Market by End User
    9.5.5.2 Argentina Cholera Vaccines Market
    9.5.5.2.1 Argentina Cholera Vaccines Market by Product
    9.5.5.2.2 Argentina Cholera Vaccines Market by End User
    9.5.5.3 Rest of South and Central America Cholera Vaccines Market
    9.5.5.3.1 Rest of South and Central America Cholera Vaccines Market by Product
    9.5.5.3.2 Rest of South and Central America Cholera Vaccines Market by End User

    10. INDUSTRY LANDSCAPE
    10.1. MERGERS AND ACQUISITIONS
    10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    10.3. NEW PRODUCT LAUNCHES
    10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    11. CHOLERA VACCINES MARKET, KEY COMPANY PROFILES
    11.1. VALNEVA SE
    11.1.1. Key Facts
    11.1.2. Business Description
    11.1.3. Products and Services
    11.1.4. Financial Overview
    11.1.5. SWOT Analysis
    11.1.6. Key Developments
    11.2. SANOFI
    11.2.1. Key Facts
    11.2.2. Business Description
    11.2.3. Products and Services
    11.2.4. Financial Overview
    11.2.5. SWOT Analysis
    11.2.6. Key Developments
    11.3. ASTELLAS PHARMA, INC
    11.3.1. Key Facts
    11.3.2. Business Description
    11.3.3. Products and Services
    11.3.4. Financial Overview
    11.3.5. SWOT Analysis
    11.3.6. Key Developments
    11.4. INTERVET INC
    11.4.1. Key Facts
    11.4.2. Business Description
    11.4.3. Products and Services
    11.4.4. Financial Overview
    11.4.5. SWOT Analysis
    11.4.6. Key Developments
    11.5. GLAXOSMITHKLINE PLC
    11.5.1. Key Facts
    11.5.2. Business Description
    11.5.3. Products and Services
    11.5.4. Financial Overview
    11.5.5. SWOT Analysis
    11.5.6. Key Developments
    11.6. PFIZER, INC
    11.6.1. Key Facts
    11.6.2. Business Description
    11.6.3. Products and Services
    11.6.4. Financial Overview
    11.6.5. SWOT Analysis
    11.6.6. Key Developments
    11.7. TAKEDA PHARMACEUTICAL CO., LTD
    11.7.1. Key Facts
    11.7.2. Business Description
    11.7.3. Products and Services
    11.7.4. Financial Overview
    11.7.5. SWOT Analysis
    11.7.6. Key Developments
    11.8. EMERGENT BIOSOLUTIONS INC.
    11.8.1. Key Facts
    11.8.2. Business Description
    11.8.3. Products and Services
    11.8.4. Financial Overview
    11.8.5. SWOT Analysis
    11.8.6. Key Developments
    11.9. EUBIOLOGICS CO., LTD
    11.9.1. Key Facts
    11.9.2. Business Description
    11.9.3. Products and Services
    11.9.4. Financial Overview
    11.9.5. SWOT Analysis
    11.9.6. Key Developments
    11.10. JOHNSON AND JOHNSON
    11.10.1. Key Facts
    11.10.2. Business Description
    11.10.3. Products and Services
    11.10.4. Financial Overview
    11.10.5. SWOT Analysis
    11.10.6. Key Developments

    12. APPENDIX
    12.1. ABOUT THE INSIGHT PARTNERS
    12.2. GLOSSARY OF TERMS
    The List of Companies

    1. Valneva SE
    2. Sanofi
    3. Astellas Pharma, Inc
    4. Intervet Inc
    5. GlaxoSmithKline plc
    6. Pfizer, Inc
    7. Takeda Pharmaceutical Co., Ltd
    8. Emergent BioSolutions Inc.
    9. Eubiologics Co., Ltd
    10. Johnson and Johnson
    TIPRE00004078
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.